A carregar...
Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Cetuximab and panitumumab, as the highly effective antibodies targeting epidermal growth factor receptor (EGFR), have clinical activity in the patients with metastatic colorectal cancer (mCRC). These agents have good curative efficacy, but drug resistance also exists at the same time. The effects of...
Na minha lista:
| Publicado no: | Gastroenterol Rep (Oxf) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333932/ https://ncbi.nlm.nih.gov/pubmed/32665850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|